Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.
Schwotzer R, Flammer AJ, Gerull S, Pabst T, Arosio P, Averaimo M, Bacher VU, Bode P, Cavalli A, Concoluci A, Dirnhofer S, Djerbi N, Dobner SW, Fehr T, Garofalo M, Gaspert A, Heimgartner R, Hübers A, Jung HH, Kessler C, Knöpfel R, Laptseva N, Manka R, Mazzucchelli L, Meyer M, Mihaylova V, Monney P, Mylonas A, Nkoulou R, Pazhenkottil A, Pfister O, Rüfer A, Schmidt A, Seeger H, Stämpfli SF, Stirnimann G, Suter T, Théaudin M, Treglia G, Tzankov A, Vetter F, Zweier M, Gerber B. Schwotzer R, et al. Among authors: kessler c. Swiss Med Wkly. 2020 Dec 5;150:w20364. doi: 10.4414/smw.2020.20364. eCollection 2020 Nov 30. Swiss Med Wkly. 2020. PMID: 33277911 Free article.
Management of transthyretin amyloidosis.
Condoluci A, Théaudin M, Schwotzer R, Pazhenkottil AP, Arosio P, Averaimo M, Bacher U, Bode P, Cavalli A, Dirnhofer S, Djerbi N, Dobner S, Fehr T, Garofalo M, Gaspert A, Gerull S, Heimgartner R, Hübers A, Jung HH, Kessler C, Knöpfel R, Laptseva N, Magini G, Manka R, Mazzucchelli L, Meyer M, Mihaylova V, Monney P, Mylonas A, Nkoulou R, Pabst T, Pfister O, Rüfer A, Schmidt A, Seeger H, Stämpfli SF, Stirnimann G, Suter T, Treglia G, Tzankov A, Vetter F, Zweier M, Flammer AJ, Gerber B. Condoluci A, et al. Among authors: kessler c. Swiss Med Wkly. 2021 Oct 20;151:w30053. doi: 10.4414/smw.2021.w30053. eCollection 2021 Oct 11. Swiss Med Wkly. 2021. PMID: 34694105 Free article.
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis.
Marchi F, Kessler C, Distefano D, Terzi di Bergamo L, Fumagalli L, Averaimo M, Crupi E, Bergamini F, Melli G, Stussi G, Rossi D, Gobbi C, Ripellino P, Pravatà E, Kuhlen DE, Röcken C, Scarone P, Gerber B, Condoluci A. Marchi F, et al. Among authors: kessler c. Amyloid. 2023 Dec;30(4):416-423. doi: 10.1080/13506129.2023.2230516. Epub 2023 Jul 11. Amyloid. 2023. PMID: 37431662 Free article.
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.
Kessler C, Stricker H, Demundo D, Elzi L, Monotti R, Bianchi G, Llamas M, Spinedi L, Rossi D, Chiesa AF, Pagnamenta A, Conti M, Casso G, Stoira E, Valenti E, Colucci G, Stussi G, Gerber B, Previsdomini M. Kessler C, et al. J Thromb Thrombolysis. 2020 Nov;50(4):833-836. doi: 10.1007/s11239-020-02244-y. J Thromb Thrombolysis. 2020. PMID: 32803737 Free PMC article. No abstract available.
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial.
Fumagalli RM, Voci D, Bikdeli B, Bingisser R, Colucci G, Forgo G, Gerardi T, Gerber B, Grigorean A, Klok FA, Righini M, Robert-Ebadi H, Stortecky S, Ulrich S, Wolf S, Wyss D, Hobohm L, Kucher N, Barco S; OVID investigators. Fumagalli RM, et al. Res Pract Thromb Haemost. 2024 Jul 26;8(5):102534. doi: 10.1016/j.rpth.2024.102534. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39252826 Free PMC article.
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Barco S, Voci D, Held U, Sebastian T, Bingisser R, Colucci G, Duerschmied D, Frenk A, Gerber B, Götschi A, Konstantinides SV, Mach F, Robert-Ebadi H, Rosemann T, Simon NR, Spechbach H, Spirk D, Stortecky S, Vaisnora L, Righini M, Kucher N; OVID investigators. Barco S, et al. Lancet Haematol. 2022 Aug;9(8):e585-e593. doi: 10.1016/S2352-3026(22)00175-2. Epub 2022 Jun 30. Lancet Haematol. 2022. PMID: 35779558 Free PMC article. Clinical Trial.
Scoping review meets expert interviews: Key issues of multimodal programs for workplace health promotion in long-term care facilities - "We can't just run a standard program".
Czakert J, Schirmaier A, Blakeslee SB, Stritter W, Koch AK, Kessler C, Seifert G. Czakert J, et al. Among authors: kessler c. Health Promot Perspect. 2024 Oct 31;14(3):221-237. doi: 10.34172/hpp.42899. eCollection 2024. Health Promot Perspect. 2024. PMID: 39633621 Free PMC article. Review.
Patient-Relevant Digital-Motor Outcomes for Clinical Trials in Hereditary Spastic Paraplegia Type 7: A Multicenter PROSPAX Study.
Beichert L, Seemann J, Kessler C, Traschütz A, Müller D, Dillmann-Jehn K, Ricca I, Satolli S, Basak NA, Coarelli G, Timmann D, Gagnon C, van de Warrenburg BPC; PROSPAX Consortium; Ilg W, Synofzik M, Schüle R. Beichert L, et al. Among authors: kessler c. Neurology. 2024 Dec 24;103(12):e209887. doi: 10.1212/WNL.0000000000209887. Epub 2024 Dec 2. Neurology. 2024. PMID: 39621946 Free PMC article.
963 results